Testing effectiveness (Phase 2)UnknownNCT02069418
What this trial is testing
Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient
Who this might be right for
Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer RecurrentNo EGFR Activating Mutation
University Hospital, Angers 80